GlaxoSmithKline Pharmaceuticals Ltd. Financials: Quarterly Results
Revenue
1073.38
Cr.
PAT
295.62
Cr.
EBITDA
383.14
Cr.
GlaxoSmithKline Pharmaceuticals Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 1041.26 | 979.94 | 805.17 | 974.37 | 949.42 |
| Total Income From Operations (Cr.) | 1041.26 | 979.94 | 805.17 | 974.37 | 949.42 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 383.14 | 351.87 | 279.40 | 359.15 | 308.19 |
| P/L Before Exceptional Items & Tax (Cr.) | 381.95 | 351.36 | 278.98 | 358.57 | 308.10 |
| P/L After Tax from Ordinary Activities (Cr.) | 295.62 | 257.49 | 205.01 | 262.87 | 229.88 |
| Net Profit/Loss For the Period (Cr.) | 295.62 | 257.49 | 205.01 | 262.87 | 229.88 |
| Basic EPS | 16.54 | 15.20 | 12.10 | 15.52 | 13.57 |
FAQs
GlaxoSmithKline Pharmaceuticals Ltd. announced its quarterly results for Q3 FY2026 on February 9, 2026.
In Q3 FY2026, GlaxoSmithKline Pharmaceuticals Ltd. are as follows:
Revenue: ₹1073.38 crore
Net Profit: ₹295.62 crore.
For Q3 FY2026, GlaxoSmithKline Pharmaceuticals Ltd. posted ₹1073.38 crore in revenue and ₹295.62 crore in net profit.
Past quarterly results for GlaxoSmithKline Pharmaceuticals Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.